Translational Psychiatry · 2013 · 260 citations · 42 references
Life SciencesImmunologyNeuroscienceAutism Spectrum DisordersAutoimmunityNeuroimmunologyAutoantibodiesAutoantigensDevelopmental NeurologyNeurodevelopmental DisordersPediatric NeuroimmunologyPregnancy ImmunologyAutism Spectrum TraitsCns AutoantibodiesConfidence Intervals For Odds RatiosEtiologic HypothesisMaternal Neuroimmune InteractionsNeuroimmune Antibody BiomarkersPathogenic AutoantibodiesReactivity
Autism spectrum disorders (ASDs) are neurodevelopmental in origin, affecting an estimated 1 in 88 children in the United States. We previously described ASD-specific maternal autoantibodies that recognize fetal brain antigens. Herein, we demonstrate that lactate dehydrogenase A and B (LDH), cypin, stress-induced phosphoprotein 1 (STIP1), collapsin response mediator proteins 1 and 2 (CRMP1, CRMP2) and Y-box-binding protein to comprise the seven primary antigens of maternal autoantibody-related (MAR) autism. Exclusive reactivity to specific antigen combinations was noted in 23% of mothers of ASD children and only 1% of controls. ASD children from mothers with specific reactivity to LDH, STIP1 and CRMP1 and/or cypin (7% vs 0% in controls; P<0.0002; odds ratios of 24.2 (95% confidence interval: 1.45-405)) had elevated stereotypical behaviors compared with ASD children from mothers lacking these antibodies. We describe the first panel of clinically significant biomarkers with over 99% specificity for autism risk thereby advancing our understanding of the etiologic mechanisms and therapeutic possibilities for MAR autism.
42
Neuroglial activation and neuroinflammation in the brain of patients with autism
Diana Vargas, Caterina Nascimbene, Chitra Krishnan et al. · Annals of Neurology · 2004 · 2.1K citations
Medicine, Neurobiology, Neuroscience +17
Database resources of the National Center for Biotechnology
David Wheeler · Nucleic Acids Research · 2003 · 1.2K citations